Pre-IPO investing can provide access to high-growth companies before they become publicly traded, but private-market transactions involve limited liquidity, less financial disclosure, and complex transfer rules. Cerebras attracted substantial investor attention because of its AI computing technology and rapid valuation growth, having raised $1.1 billion at an $8.1 billion valuation in 2024. Updated August 2026, the guide explains how investors could evaluate pre-IPO access to Cerebras and how popular private marketplaces compare. Augment is a private-stock marketplace connecting verified shareholders with accredited investors, supporting transactions through a centralized marketplace and reporting access to more than 300 pre-IPO companies, although this does not confirm Cerebras availability. The platform verifies investors and sellers before participation, and most private-market opportunities are designed for accredited investors. Augment advertises minimum investments beginning at $10,000 and states that some structures do not charge management fees or carry interest. Secondary marketplaces may improve access and price visibility, but investors can face liquidity discounts, incomplete information, uncertain resale opportunities, and company-controlled transfer or ROFR requirements. Private-stock transactions remain subject to securities rules and company transfer requirements, and rights of first refusal may affect whether a transaction closes. Investors would have needed to confirm whether Cerebras shares were available, as general marketplace coverage did not guarantee an active opportunity. Augment’s pricing could be compared with Cerebras’ funding-round valuation, while share class and transfer restrictions could affect the investment’